Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
- Resource Type
- Article
- Source
- In
American Heart Journal 2011 162(1):98-105 - Subject
- Language
- ISSN
- 0002-8703